People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other, Pharmaceuticals, Other Technology, Biotechnology, Restaurants
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Noesis Energy, Inc. | — | Other | Series A | $26.1M | $75.7M | 2011 |
| EyePoint Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $25.6M | $437.8M | 2020 |
| Mog Inc | — | Other | Series A | $18.7M | $46.0M | 2009 |
| Powerfile Inc | — | Other Technology | Series A | $11.7M | $325.1M | 2009 |
| Tunesat, LLC | — | Other Technology | Series A | $9.0M | $4.9M | 2011 |
| Taseko Mines Ltd | — | Other | Seed | $3.2M | $59.6M | 2009 |
| EXSULIN Corp | — | Biotechnology | Pre-Seed | $1.0M | $8.5M | 2009 |
| 4000 Nachos Partners, LP | — | Restaurants | Pre-Seed | $950K | $700K | — |
| Cowtown Diner, LP | — | Restaurants | Pre-Seed | $880K | $1.2M | — |
| Brand Passport, Inc. | — | Other | Pre-Seed | $768K | $17.8M | 2012 |
| Desert Forest Golf Club, Inc. | — | Other | Pre-Seed | $700K | $16.2M | 2013 |
Scott Jones at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Jones on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Pacitti | 1 | 14 |
| Greg McAdoo | 1 | 7 |
| Christopher Woods | 1 | 7 |
| Sonja Hoel Perkins | 1 | 7 |
| TREVOR THOMAS | 1 | 6 |
| James Barry | 1 | 5 |
| William Foster | 1 | 4 |
| DAVID ELLIOTT | 1 | 4 |
| Douglas Godshall | 1 | 4 |
| Robert Cox | 1 | 4 |
| Robert Day | 1 | 3 |
| Mark Masur | 1 | 3 |
| Thomas Daly | 1 | 3 |
| Todd Steele | 1 | 3 |
| David Hyman | 1 | 3 |
| Michael Rogers | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Rick Rubin | 1 | 3 |
| Dan Warmenhoven | 1 | 3 |
| David Mazzo | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.